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Design Objectives
1. Produce a defined structure from spider silk protein 
using a 3D printer.
2. Maintain inherent biocompatibility of synthetic 
spider silk proteins.
3. Achieve comparable mechanical properties to 
similar implants used in medicine.
Introduction
At $3.07 billion in 2013, the 3D printing industry was 
projected to reach $12.8 billion in 2018 and exceed $21 
billion by 2020 [1]. A lucrative part of this expanding 
industry includes printing biocompatible medical 
implants, devices and tissue scaffolds. A common 
problem encountered with traditional devices and 
implants, is that they are not unique to the patient, 
making the surgeries more difficult and less effective. 
Tissue scaffolds could also benefit from increased 
strength and biocompatibility. To answer these 
demands, customizable devices are being produced 
from patient medical scans and CAD designs using 3D 
printers.  Traditionally, plastics such as poly (lactic acid) 
(PLA) or poly (lactic-co-glycolic) acid (PLGA) are used in 
3D printers because of their thermoplastic properties, 
which make them easy to print. These plastics are 
typically regarded as biocompatible but can degrade to 
less biocompatible forms in the body and leave the 
implant site, causing inflammatory and foreign body 
responses. Because of these problems, there has been a 
focus on developing new biomaterials for making 
customizable and highly biocompatible, resorbable 
implants.      
A 3D printer system comprised of a synthetic spider silk 
resin and a modified 3D printer was developed. A fused 
filament 3D printer, purchased for under $550, was 
modified with a custom syringe pump design. This 
syringe pump allowed for the extrusion of spider silk 
proteins through a needle, producing defined 
structures. Cell studies were performed on these 
structures which showed favorable cell attachment and 
growth. As an alternative 3D printed biomaterial, spider 
silk is capable of entering various emerging industries.
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Conclusion
Therefore the project was successful  in designing an 
inexpensive 3D printing system comprised of a spider 
silk protein resin and modified FDM 3D printer that 
produced defined spider silk structures. An aspect ratio 
of 4.8, 29.3% cell inhibition, and compressive stress of 
65.1+ 12.2 kPa were achieved. The system provides a 
reliable platform on which to continue research.
Future Work
With the printing system in place, further studies will be 
conducted to test the silk’s ability to perform as a 
medical implant material and tissue scaffold. Additional 
medical scans of increasing complexity will also be 
printed to test the applicable resolution of the printer, 
similar to the hyoid bone print seen in Figure 1f-g.
Discussion
3D Printer Design
The total cost of the designed 3D printer was 
significantly less than commercially available aqueous 
3D printers  (see Table 1). The silk was also able to be 
printed at an aspect ratio of 4.8 (see Table 1, Figure 1e)
Biocompatibility
It was found that all resins inhibited cell growth  with 
the lowest inhibition being 29.3% when compared to 
the controls (see Table 1). However, favorable cell 
attachment was shown (see Figure 1d).
Mechanical Data
The printed spider silk had a greater Elastic Modulus 
than those reported in literature for 3D printed B. mori 
silk. However, the spider silk had significantly lower 
shear values than those reported for PLGA (see Table 1).
Methods
Resin Formulation
Two spider silk protein resins were developed from 
rMaSp1 and rMaSp1 recombinant spider silk proteins 
derived from goats.  The first was 6% by weight in 
a 50:50 ratio and the second was a 12% rMaSp1 only.
Printer Setup
The modified Printrbot Simple Metal, as shown in 
Figure 1a, uses Cura software. The printer was modified 
with a 3D printed syringe pump utilizing a 5 ml syringe 
and a 0.7 mm diameter needle (see Figure 1b).
Biocompatibility Test
This was performed using an alamarBlue™ assay. Thin 
resin films in 6 well plates were seeded with 300,000 
goat fetal fibroblasts per well. 200ul of alamarBlue™ 
was added to each well and allowed to permeate the 
cells for 6 hours before absorbance readings were taken 
at 570 nm and 600 nm in a UV/VIS spectrophotometer.
Mechanical Testing
Simple structures were post-treated  by soaking in 
either IPA, IPA & Cross-linking Solution (XLS),  or XLS 
only for 24 hours. These were tested in shear and to the 
bio-yield point in compression on a 50 N load cell.
Applications
Tissue 
Engineering
Medical 
Implants
Figure 1. A) Completed system with modified syringe pump attached to 
Printrbot Simple Metal 3D printer, B) CAD rendering of syringe pump 
mechanism, C) Printed 5mm x 8mm spider silk cylinder used in 
mechanical testing (4mm scale bar), D) Goat fetal fibroblast cells 
showing favorable growth on cured spider silk resin, E) 3D printed spider 
silk showing aspect ratio, F) Scanned model of human hyoid bone (NIH 
3D Print Exchange), G) 3D printed spider silk hyoid bone dyed blue and 
scaled down by ¼ (7mm scale bar).
Table 1. Final Results
Characteristic
Printer Design
Total Cost $635
*Cost of Commercial Lab 3D Printer $100-150 K
Aspect Ratio 4.8
Number of Spider Silk Protein Resins 2
AlamarBlue™ Assay: Cell Growth Inhibition † 
12% rMaSp1 Cross-linked 29.3%
6% rMaSp1:rMaSp2 IPA Post-treated 72.9%
6% rMaSp1:rMaSp2 42.2%
Mechanical Data
Maximum Stress – Compression 65.1 + 12.2 kPa
Energy to Break 10.7 + 2.3 kPa
Elastic Modulus 555.8 + 215.1 kPa
*Elastic Modulus 3D Printed B. Mori Silk ~0.2 kPa
Maximum Strain 0.247 + 0.037 kPa
Maximum Stress – Shear 522 + 403 kPa
*PLGA – Shear ~100 MPa
Data are presented as mean + standard deviation
*Values from literature
†Values are percentages with respect to the controls
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